SR Ca2+-ATPase activity and expression in ventricular myocardium of dogs with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Gupta, Ramesh C ^a,b   Shimoyama, Hisashi ^a   Tanimura, Mitsuhiro ^a   Nair, Rajiv ^a   Lesch, Michael ^a   Sabbah, Hani N ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Monoclonal antibody; Right ventricle; Ventricular function; Western blotting

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

EID: 0030875111     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.1.h12     Document Type: Article

References (33)

1. Afzal, N., and N. S. Dhalla. Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H868-H874, 1992.
2. Arai, M., H. Matsui, and M. Periasamy. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 74: 555-564, 1994.
3. Carafoli, E. R., R. Tiozzo, G. Lugli, F. Crovetti, and C. Kratzing. The release of calcium from heart mitochondria by sodium. J. Mol. Cell. Cardiol. 6: 361-371, 1974.
4. 2+ channel in SR from dogs with heart failure. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H926-H937, 1993.
5. Cory, C. R., R. W. Grange, and M. E. Houston. Role of sarcoplasmic reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H68-H78, 1994.
6. Davies, D. H., K. Davia, J. G. Bennet, J. R. Pepper, P. A. Poole-Wilson, and S. E. Harding. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92: 2540-2549, 1995.
7. Dodge, H. T., H. Sandler, W. A. Baxley, and R. R. Hawley. Usefulness and limitations of radiographic methods determining left ventricular volume. Am. J. Cardiol. 18: 10-24, 1966.
8. Gupta, R. C., B. A. Davis, and E. G. Kranias. Mechanism of the stimulation of cardiac sarcoplasmic reticulum calcium pump by calmodulin. Membr. Biochem. 7: 73-86, 1988.
9. Gupta, R. C., J. Neumann, J, A. M. Watanabe, M. Lesch, and H. N. Sabbah. Evidence for the presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocytes. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1159-H1164, 1996.
10. Harigaya, S., and A. Schwartz. Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Circ. Res. 25: 781-794, 1969.
11. Hartzell, H. C. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger system. Prog. Biophys. Mol. Biol. 52: 165-247, 1988.
12. 2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75: 434-442, 1994.
13. 2+-transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ. Res. 77: 759-764, 1995.
14. Konstam, M. A., M. F. Rousseau, M. W. Kronenberg, J. E. Udelson, J. Melin, D. Stewart, N. Dolan, T. R. Edens, S. Ahn, D. Kinan, D. M. Howe, L. Kilcocyne, J. Metherall, C. Benedict, S. Yusuf, and H. Pouleur. Effects of the angiotensin-converting enzyme inhibitor enalapril on long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86: 431-438, 1992.
15. 2+ transport by cyclic 3′,5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 844: 193-199, 1985.
16. Lowry, O. H., and J. A. Lopez. The determination of inorganic phosphate in the presence of labile phosphate esters. J. Biol. Chem. 162: 421-424, 1946.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. Lytton, J., M. Westlin, and M. R. Hanley. Thapsigargin inhibits the sarcoplasmic reticulum or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 266: 17067-17071, 1991.
19. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J. Clin. Invest. 85: 305-309, 1990.
20. Meyer, M., W. Schillinger, B. Pieske, C. Holubarsch, C. Heilmann, H. Posival, G. Kuwajima, K. Mikoshiba, H. Just, and G. Hasenfuss. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
21. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ. Res. 65: 1141-1144, 1989.
22. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994.
23. 2+ accumulation in nonfailing and failing human myocardium. Circulation 92: 2504-2510, 1995.
24. Presti, C. F., L. R. Jones, and J. P. Lindemann. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J. Biol. Chem. 260: 3860-3867, 1985.
25. Sabbah, H. N., H. Shimoyama, T. Kono, R. C. Gupta, V. G. Sharov, G. Scicli, T. B. Levine, and S. Goldstein. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89: 2852-2859, 1994.
26. Sabbah, H. N., P. D. Stein, T. Kono, M. Gheorghiade, T. B. Levine, S. Jafri, E. T. Hawkins, and S. Goldstein. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1379-H1384, 1991.
27. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
28. Sharov, V. G., H. N. Sabbah, H. Shimoyama, A. S. Ali, T. B. Levine, M. Lesch, and S. Goldstein. Abnormalities of contractile structures in viable myocytes of the failing heart. Int. J. Cardiol. 43: 287-297, 1994.
29. Sharov, V. G., H. N. Sabbah, H. Shimoyama, A. V. Goussev, M. Lesch, and S. Goldstein. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148: 141-149, 1996.
30. Solaro, R. J., D. C. Pang, and F. N. Briggs. The purification of cardiac myofibrils with Triton X-100. Biochim. Biophys. Acta 245: 259-262, 1971.
31. Spinale, F. G., B. M. Fulbright, R. Mukherjee, R. Tanaka, J. Hu, F. A. Crawford, and M. R. Zile. Relation between ventricular and myocyte function with tachycardia-induced cardiomyopathy. Circ. Res. 71: 174-187, 1992.
32. 2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban specific monoclonal antibody. J. Biol. Chem. 261: 7018-7023, 1986.
33. Whitmer, J. T., K. Pankaj, and R. J. Solaro. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ. Res. 62: 81-85, 1988.